Synthetic Data Market Survey 2020

Posted on: 09/10/2020

KTN has released a survey on synthetic data with the Medicines and Healthcare products Regulatory Agency (MHRA)

What is this survey about?

In recent times, there has been growing interest in the use of synthetic patient datasets that could overcome challenges in data access either because of a lack of suitable ‘real’ patient data sources or because of data governance considerations.
The aim of this survey is to ascertain whether such high-fidelity synthetic datasets are likely to be of use to you or your organisation and identify priority needs that would provide the most benefit to Health Tech innovators and to public health. Your responses will be treated in confidence and be anonymised in any published reports.
The survey deadline has been extended until the end of November 2020.

What do we mean by synthetic data?

The concept of synthetic data has been around for many years but, mostly, referred to real data that had been modified in some way. Truly artificial data could only be simulated for a few data fields and only for very simple data. This has now changed with recent developments in synthetic data generation that can yield ‘high-fidelity’ synthetic patient datasets that are completely artificial, yet indistinguishable from real data. These datasets can also replicate the complex clinical relationships found in real patient data without compromising patient privacy. See for example the recent work in this area pioneered by the Medicines and Healthcare products Regulatory Agency (MHRA) and exemplar synthetic datasets made available by them.

How will this survey data be used?

KTN has produced and distributed this survey to enable the MHRA to evaluate the potential benefit of validated synthetic data sets to private and public sector innovators and businesses.
The Medicines and Healthcare products Regulatory Agency enhances and improves the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research. The MHRA regulatory centre is the UK regulator of blood, medicines and medical devices and the Clinical Practice Research Datalink (CPRD) is the leading provider of integrated real-world research services using anonymised NHS clinical data to improve public health. For further information please see the MHRA website. The data collected in this survey will be shared with MHRA. This survey can be completed anonymously, or you can provide contact details and your consent to share your contact details with MHRA for possible follow up interviews with MHRA.
Please click here to access the survey.

Share this article


Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.